GO:1902775 mitochondrial large ribosomal subunit assembly

The mitochondrial large ribosomal subunit (39S or mitoribosome large subunit) is the catalytic core of mitochondrial protein synthesis, and its assembly is a highly regulated process annotated as GO:1902775, mitochondrial large ribosomal subunit assembly. This biological process encompasses the aggregation, arrangement, and bonding together of a set of components to form a functional large subunit, a prerequisite for translation of the 13 mtDNA-encoded OXPHOS subunits. Because the mitoribosome is a ribonucleoprotein machine with a reversed rRNA-to-protein ratio compared with bacterial ribosomes, its assembly requires numerous nuclear-encoded assembly factors that transiently associate with assembly intermediates. Understanding GO:1902775 is therefore central to mitochondrial biology, as defects in this pathway impair oxidative phosphorylation and cause severe human disorders. Recent studies have begun to resolve the stepwise assembly of the human mitoribosome large subunit, revealing late-stage checkpoints that monitor the incorporation of key proteins and rRNA modules. For example, GTPBP8 is a GTPase that participates in mitoribosome formation and is required for efficient large subunit assembly in human mitochondria. In yeast, the DEAD-box protein Mrh4 functions in large subunit assembly, and the zinc finger motif of bL36m is essential for optimal assembly and function. These findings highlight that GO:1902775 is not a spontaneous self-assembly process but an orchestrated pathway involving energy-consuming enzymes and quality-control steps. For researchers, GO:1902775 provides a framework to interpret genetic, proteomic, and structural data on mitochondrial ribosome biogenesis. Mutations in assembly factors or ribosomal proteins can stall specific steps, leading to the accumulation of assembly intermediates that can be detected by quantitative proteomics and cryo-electron microscopy. Moreover, the pathway is sensitive to the mitochondrial methylation potential, linking one-carbon metabolism to mitoribosome assembly. This article synthesizes the current understanding of GO:1902775, its key genes, regulatory inputs, disease relevance, and the experimental models used to study it.

GO:1902775, mitochondrial large ribosomal subunit assembly, is defined by the Gene Ontology as the aggregation, arrangement and bonding together of a set of components to form a mitochondrial large ribosomal subunit. In practice, this means the ordered assembly of mitochondrial rRNAs, mitochondrial ribosomal proteins (MRPs), and transient assembly factors into the 39S large subunit of the mitoribosome, a process that occurs in the mitochondrial matrix and inner membrane compartments and is required for mitochondrial translation.

GO:1902775 is important because the mitochondrial large ribosomal subunit is the site of peptidyl transferase activity in mitochondria, and its correct assembly is essential for the synthesis of mtDNA-encoded OXPHOS subunits. Disruption of this assembly process leads to impaired mitochondrial translation, reduced oxidative phosphorylation capacity, and a spectrum of human diseases, including Leigh syndrome and other mitochondrial encephalomyopathies. Furthermore, the assembly pathway is emerging as a target for understanding how mitochondrial function is integrated with cellular metabolism, as shown by the role of the mitochondrial methylation potential in gating mitoribosome assembly.

The following genes and proteins are experimentally implicated in mitochondrial large ribosomal subunit assembly (GO:1902775) based on the verified literature.

Mitochondrial large ribosomal subunit assembly is regulated at multiple levels. The mitochondrial methylation potential gates mitoribosome assembly, linking one-carbon metabolism to the assembly process. GTP hydrolysis by assembly factors such as GTPBP8 provides energy and timing for assembly steps. Late-stage assembly checkpoints ensure quality control before the large subunit joins the small subunit. Additionally, the availability of nuclear-encoded ribosomal proteins and assembly factors, which are synthesized in the cytosol and imported into mitochondria, is a regulatory node. The DEAD-box protein Mrh4 in yeast is regulated in response to metabolic state, suggesting that assembly is coupled to cellular energy status.

Defects in mitochondrial large ribosomal subunit assembly impair mitochondrial translation and oxidative phosphorylation, leading to mitochondrial disease. Nuclear gene-encoded Leigh syndrome spectrum disorders include mutations in mitoribosome assembly factors and ribosomal proteins, presenting with progressive neurodegeneration, lactic acidosis, and bilateral basal ganglia lesions. Pathogenic variants in MRPL3 and other large subunit proteins have been reported in patients with OXPHOS deficiency. The late-stage assembly checkpoint is particularly vulnerable, as mutations that stall assembly can cause accumulation of toxic intermediates.

Altered mitochondrial translation is increasingly recognized in cancer, where cancer cells reprogram metabolism to support proliferation. Assembly factors such as GTPBP8 may be dysregulated in tumors, and the methylation potential that gates mitoribosome assembly is often altered in cancer. Targeting mitoribosome assembly could therefore be a therapeutic strategy, although direct evidence in cancer models is still emerging.

Mitochondrial dysfunction is a hallmark of aging and neurodegeneration. Impaired mitoribosome assembly can lead to reduced OXPHOS capacity and increased reactive oxygen species, contributing to neuronal death. The zinc finger motif of bL36m, which is essential for optimal assembly, may be particularly susceptible to oxidative damage, linking assembly defects to age-related decline.

Affinity purification of tagged assembly factors followed by mass spectrometry can identify the composition of assembly intermediates and reveal the order of protein incorporation. This method is particularly powerful when combined with CRISPR knock-in of tags into endogenous loci.

Ribo-seq measures mitochondrial translation efficiency and can detect defects in large subunit assembly that impair translation. It is often used after knockout of candidate assembly factors to assess functional consequences.

Cryo-EM of assembly intermediates provides near-atomic resolution snapshots of the assembly pathway and has been used to define late-stage checkpoints. This method requires purification of assembly intermediates, often via affinity tags.

Yeast models allow rapid genetic manipulation and biochemical analysis of conserved assembly factors such as Mrh4 and bL36m. Growth assays, polysome profiling, and mitochondrial translation assays are commonly used.

Researchers studying mitochondrial large ribosomal subunit assembly-related genes often need to determine whether a candidate gene is causally involved in the assembly pathway or merely correlated with it. CRISPR-based models provide the gold standard for such causal tests, enabling precise genetic perturbations that can be interrogated with proteomics, Ribo-seq, and imaging.

GO:1902775, mitochondrial large ribosomal subunit assembly, is a fundamental biological process required for mitochondrial translation and oxidative phosphorylation. Recent studies have revealed a stepwise, checkpoint-controlled pathway involving GTPases, DEAD-box proteins, and methylation-dependent regulation. Defects in this pathway cause severe mitochondrial diseases, making it a critical area of research. CRISPR-based models, combined with proteomics and structural biology, will continue to illuminate the mechanisms of assembly and identify therapeutic targets.